#Predicting prostate cancer: Nanotechnology shows promise for more accurate prostate cancer screening and prognosis Abstract:
A Northwestern University-led study in the emerging field of nanocytology could one day help men make better decisions about
whether or not to undergo aggressive prostate cancer treatments. Technology developed by Northwestern University researchers may help solve that quandary by allowing physicians to identify which nascent cancers are likely to escalate into potentially life-threatening malignancies and
which ones will remain"indolent,"or nonaggressive. The prostate specific-antigen antigen (PSA) test was recommended once the screening tool for detecting prostate cancer,
but there is now disagreement over the use of this test because it can't predict which men with elevated PSA levels will actually develop an aggressive form of the disease."
"If we can predict a prognosis with our technology, then men will know if their cancer is dangerous
and if they should seek treatment, "said Vadim Backman, senior author of the study.""Right now there is no perfect tool to predict a prognosis for prostate cancer.
Our research is preliminary, but it is promising and proves that the concept works.""Backman is a professor of biomedical engineering at Northwestern's Mccormick School of engineering and Applied science.
Northshore University Healthsystem (Northshore) and Boston Medical center, was published online in PLOS ONE. Backman has been studying cell abnormalities at the nanoscale in many different types of cancers,
using an optical technique he pioneered called partial wave spectroscopic (PWS) microscopy. PWS can detect cell features as small as 20 nanometers,
This is the first study to use PWS to predict a cancer prognosis, the likely course of the disease.
Prostate cancer is the second-leading cause of cancer deaths in American men, but doctors also say it is often overdiagnosed and overtreated.
By age 80, more than 50 percent of men will develop prostate cancer but not all will have the aggressive,
deadly form of the disease. However, because their prognosis is unknown, many opt for aggressive treatments that have side effects that cause urinary,
bowel and erectile dysfunctions and more.""The goal is to find specific biomarkers of aggressive cancers,
"said Charles Brendler, MD, Co-Director of the John and Carol Walter Center for Urological Health & Program for Personalized Cancer Care at Northshore and author of the study."
"These biomarkers will allow us to individualize our treatment recommendations and improve patient outcomes.""To be able to give a patient a prognosis,
not just identification of risk of tumors, would be said a major advancement Dr. Hemant K. Roy professor of medicine and Chief of gastroenterology at Boston Medical center and an author of the study."
"This approach may allow tailoring of clinical decisions regarding management of patients with prostate cancer,
thus maximizing the benefit and minimizing the harms of therapy, "Roy said. In this study, researchers analyzed prostate tissue biopsies from two cohorts of prostate cancer patients.
The first cohort included eight men with non-progressing cancer and 10 with progressing cancer.
The PWS operator was blinded to the clinical status of the patients. The second cohort was comprised of 10 progressors and 10 non-progressors in
which the PWS investigators were blinded to the entire group. There was a profound increase in nano-architectural disorder in the progressors as compared to the non-progressors.
This assessment may represent a powerful biomarker to predict cancer progression for men with early-stage prostate cancer."
"This study has high quality data because it was done in a blinded fashion, "Backman said.""Given that even in the unblinded dataset the investigator responsible for data acquisition was unaware of the clinical status,
Backman also hopes to use similar techniques to predict cancer progression in ovarian, breast and esophageal cancers.##
###The study authors are Hemant K. Roy of Boston Medical center; Charles B. Brendler, Karen L. Kaul, Brian T. Helfand, Chi-Hsiung Wang, Margo Quinn, Jacqueline Petkewicz and Michael Paterakos, of Northshore University Healthsystem;
News and information'Additive manufacturing'could greatly improve diabetes management March 17th, 2015harris & Harris Group Reports Financial statements as of December 31, 2014 and Posts Annual Letter to Shareholders on Website March 17th, 2015four
2015innovative light therapy reaches deep tumors March 9th, 2015a new tool for detecting and destroying norovirus March 9th,
2015the Universitat Politcnica de Valncia is coordinating a European project to develop a device for the quick and early diagnosis of cancer March 7th,
2015nanomedicine'Additive manufacturing'could greatly improve diabetes management March 17th, 2015nanotechnology Drug Delivery Market in the US 2012-2016:
Latest Report Available by Radiant Insights, Inc March 16th, 2015silver implant nanotech killing infections: NC State Industrial & Systems Engineering Research Team Arms Implants With Battery-Activated Nanotechnology March 14th, 2015turmeric Extract Applied in Production of Antibacterial Nanodrugs March 12th,
2015discoveries Stable long term operation of graphene devices achieved (Kopie 1 march 17th, 2015maps predict strength of structures:
2015announcements'Additive manufacturing'could greatly improve diabetes management March 17th, 2015harris & Harris Group Reports Financial statements as of December 31, 2014 and Posts Annual Letter to Shareholders on Website March 17th,
which facilitate a charge injection from gold, and n-type organic semiconductors, which facilitate a charge injection from silver (Figure 3). EEJA will announce the research findings relating to this technology at the 62nd Jpan Society of Applied Physics Spring Meeting,
to be held between March 11 and March 14 at Tokai University, Shonan Campus (Hiratsuka-shi, Kanagawa). Background to this technology OFET is a transistor that uses an organic semiconductor,
2015sensors The Universitat Politcnica de Valncia is coordinating a European project to develop a device for the quick and early diagnosis of cancer March 7th,
2015military The Universitat Politcnica de Valncia is coordinating a European project to develop a device for the quick and early diagnosis of cancer March 7th,
who are now exploring business opportunities for marketing the classification and determination of the degree of pluripotency of stem cells before their use in cell therapy or research in biomedicine.
thus having the capacity of becoming a standard method of quality control of stem or pluripotent cells before their use in cell therapy or research in biomedicine e
Few studies explore toxicity of cellulose nanocrystals March 10th, 2015superconductivity Electrons in slow motion: Here's how to see the'fastest slow process'--to understand superconductors March 9th, 2015strength in numbers:
Few studies explore toxicity of cellulose nanocrystals March 10th, 2015interviews/Book reviews/Essays/Reports/Podcasts/Journals/White papers Researchers synthesize new thin-film material for use in fuel cells:
March 10th, 2015photonics/Optics/Lasers Innovative light therapy reaches deep tumors March 9th, 2015quantum sensor's advantages survive entanglement breakdown:
2015the Universitat Politcnica de Valncia is coordinating a European project to develop a device for the quick and early diagnosis of cancer March 7th,
Few studies explore toxicity of cellulose nanocrystals March 10th, 2015thin films Graphene meets heat waves March 9th, 2015ciqus researchers obtain high-quality perovskites over large areas by a chemical method March 4th,
Few studies explore toxicity of cellulose nanocrystals March 10th, 2015interviews/Book reviews/Essays/Reports/Podcasts/Journals/White papers Researchers snap-shot fastest observations of superconductivity yet March 10th,
Nanobodies are very similar to antibodies, which recognize and bind to antigens.""However, nanobodies are much smaller, more stable, easier to produce,
and cost-effective than traditional monoclonal antibodies, "says Hansman. Interestingly, Nano-85 was able to recognize the VLPS from a variety of different norovirus strains.
this could be a very promising lead in developing norovirus antiviral therapy. This could be especially beneficial to immunosuppressed individuals such as cancer patients.
Administering a vaccine to protect against infection would overwhelm the patient's immune system. However, if he or she has the option of receiving an antiviral to eliminate the infection,
the norovirus becomes much less dangerous
#Microchip captures clusters of circulating tumor cells--NIH study Circulating tumor cells (CTCS) are cells that break away from a tumor and move through a cancer patient's bloodstream.
Single CTCS are extremely rare, typically fewer than 1 in 1 billion cells. These cells can take up residence in distant organs,
and researchers believe this is one mode by which cancer spreads. Even less common than single CTCS are small groups of CTCS, or clusters.
While the existence of CTC clusters has been known for more than 50 years, their prevalence in the blood as well as their role in metastasis has not been investigated thoroughly,
However, recent advances in biomedical technologies that enable researchers to capture single CTCS have renewed interest in CTC clusters,
. professor of surgery (biomedical engineering) at the Massachusetts General Hospital (MGH) and the Harvard-MIT Division of Health & Sciences Technology, report the development of a novel microfluidic chip that is specifically designed for the efficient capture of CTC clusters
"Very little is known about CTC clusters and their role in the progression and metastasis of cancer.
M d."This is the kind of breakthrough technology that could have a very large impact on cancer research."
which funds transformative technological innovation designed to solve major medical problems with a substantial disease burden,
such as preventing cancer metastasis or precisely tailoring therapeutics to an individual's cancer cell biology. Toner and his collaborator Dr. Daniel Haber, M d.,Ph d.,also at MGH, recently used Cluster-Chip to capture
and analyze CTC clusters in a group of 60 patients with metastatic breast, prostate, and melanoma cancers.
The researchers found CTC clusters--ranging from two to 19 cells--in 30-40 percent of the patients."
and occasionally clusters using antibodies that stick to special proteins found on the surface of some tumor cells.
This latter property makes the Cluster-Chip well-suited for capturing CTC clusters from a range of cancer types,
including those that lose surface proteins during metastasis and those that never express them, such as melanoma.
The researchers went on to test the Cluster-Chip in a small trial of 60 patients with metastatic cancer.
In this study, the chip captured CTC clusters in 11 of 27 (40.7 percent) breast cancer patients, 6 of 20 (30 percent) melanoma patients
and an association between the presence of clusters and reduced survival in prostate cancer patients.
the researchers measured a marker of tumor cell proliferation--an indicator of increased invasiveness and poor outcomes--in one breast cancer patient with high numbers of both single CTCS and clusters.
The researchers also noted the rare presence of non-tumor cells within clusters in less than 5 percent of patients."
"Given the increasing number of cancer therapies that engage the immune system, the ability to monitor tumor-immune cell interactions via the blood could be of great value."
"Toner anticipates that the Cluster-Chip will play an important role in stimulating new research on CTC cluster biology:"
and to develop even better technologies to understand their biology in cancer metastasis
#Computing at the speed of light: Utah engineers take big step toward much faster computers The Utah engineers have developed an ultracompact beamsplitter--the smallest on record--for dividing light waves into two separate channels of information.
New device offers clues Why do some cancer cells break away from a tumor and travel to distant parts of the body?
A team of oncologists and engineers from the University of Michigan teamed up to help understand this crucial question.
2015 Cancer becomes deadly when it spreads, or metastasizes. Not all cells have the same ability to travel through the body,
The differences in individual cancer cells are a key aspect of how cancer evolves becomes resistant to current therapies or recurs."
"A primary tumor is not what kills patients. Metastases are what kill patients. Understanding which cells are likely to metastasize can help us direct more targeted therapies to patients,
"says co-senior study author Sofia D. Merajver, M d.,Ph d.,scientific director of the breast oncology program at the University of Michigan Comprehensive Cancer Center.
The researchers believe this type of device might some day help doctors understand an individual patient's cancer.
Which cells in this patient's tumor are really causing havoc? Is there a large population of aggressive cells?
Are there specific markers or variants on those individual cells that could be targeted with treatment?"
"This work demonstrates an elegant approach to the study of cancer cell metastasis by combining expertise in engineering
"In this work, extensive studies were performed on cell lines representing various types of cancer. The new device was designed to trace how cells move, sorting individual cells by their movement.
and appearance under the microscope of metastatic cells and expressed significantly higher levels of markers associated with metastatic cancer."
"Understanding specific differences that lead some cancer cells to leave the primary tumor and seed metastases is of great benefit to develop
Patients seeking more information about their options for cancer treatment can call the U-M Cancer Answerline at 800-865-1125 5
and even medicine. Now a team of Northwestern University researchers has found a way to print three-dimensional structures with graphene nanoflakes.
The fast and efficient method could open up new opportunities for using graphene printed scaffolds regenerative engineering and other electronic or medical applications.
assistant professor of materials science and engineering at Northwestern's Mccormick School of engineering and of surgery in the Feinberg School of medicine,
"Supported by a Google Gift and a Mccormick Research Catalyst Award, the research is described in the paper"Three-dimensional printing of high-content graphene scaffolds for electronic and biomedical applications,"published in the April
so it could be used for biodegradable sensors and medical implants. Shah said the biocompatible elastomer
and at the same time absence of toxicity and flammability, and the possibility to recover oil. The creation of this graphene-based oil-adsorbent product, commercialized as Grafysorber,
2015effective Nano-Micelles Designed in Iran to Treat Cancer May 20th, 2015announcements SUNY Poly CNSE and NIOSH Launch Federal Nano Health and Safety Consortium:
2015effective Nano-Micelles Designed in Iran to Treat Cancer May 20th, 2015environment Nano-policing pollution May 13th, 2015chemists strike nano-gold:
Many thousands of times thinner than the average human hair, nanofibers are used by medical researchers to create advanced wound dressings--and for tissue regeneration
drug testing, stem cell therapies and the delivery of drugs directly to the site of infection.
Nanofibers can also be loaded with proteins, nanotubes, fluorescent materials and therapeutic agents.""We can use almost any kind of polymer with this platform,
2015nanomedicine Effective Nano-Micelles Designed in Iran to Treat Cancer May 20th, 2015nature inspires first artificial molecular pump:
Simple design mimics pumping mechanism of life-sustaining proteins found in living cells May 19th, 2015studying dynamics of ion channels May 18th, 2015organic nanoparticles, more lethal to tumors:
Carbon-based nanoparticles could be used to sensitize cancerous tumors to proton radiotherapy and induce more focused destruction of cancer cells, a new study shows May 18th,
2015effective Nano-Micelles Designed in Iran to Treat Cancer May 20th, 2015materials/Metamaterials Taking control of light emission:
, more lethal to tumors: Carbon-based nanoparticles could be used to sensitize cancerous tumors to proton radiotherapy
and induce more focused destruction of cancer cells, a new study shows May 18th, 2015wearables may get boost from boron-infused graphene:
May 6th, 2015improving Clinical Care and Patient Quality of life in Advanced Liver disease, d-LIVER Workshop, Milan, 27 may 2015 May 6th, 201 0
#Nanotechnology identifies brain tumor types through MRI'virtual biopsy'in animal studies: If results are confirmed in humans,
tumor cells could someday be diagnosed by MRI imaging and treated with tumor-specific IV injections;
new NIH grant will fund future study Abstract: Biomedical researchers at Cedars-Sinai have invented a tiny drug-delivery system that can identify cancer cell types in the brain through"virtual biopsies
"and then attack the molecular structure of the disease. If laboratory research with mice is borne out in human studies,
the results could be used to deliver nanoscale drugs that can distinguish and fight tumor cells in the brain without resorting to surgery."
"Our nanodrug can be engineered to carry a variety of drugs, proteins and genetic materials to attack tumors on several fronts from within the brain,"said Julia Ljubimova, MD, Phd,
professor of neurosurgery and biomedical sciences at Cedars-Sinai and a lead author of an article published online in the American Chemical Society's journal ACS Nano.
Ljubimova, director of the Nanomedicine Research center in the Department of Neurosurgery and director of the Nanomedicine Program at the Samuel Oschin Comprehensive Cancer Institute, has received a $2. 5 million grant from the National institutes of health to continue the research.
The drug delivery system and its component parts together called a nanobioconjugate or nanodrug, is in an emerging class of molecular drugs designed to slow
or stop cancers by blocking them in multiple ways within the brain. The drug is about 20 to 30 nanometers in size-a fraction of a human hair,
such as seeking out cancer cells and binding to them, permeating the walls of blood vessels and tumor cells,
or dismantling molecular mechanisms that promote tumor growth, "said Eggehard Holler, Phd, professor of neurosurgery and director of nanodrug synthesis at Cedars-Sinai.
The new delivery system plays two roles: diagnosing brain tumors by identifying cells that have spread to the brain from other organs,
and then fighting the cancer with precise, individualized tumor treatment. Researchers can determine tumor type by attaching a tracer visible on an MRI.
If the tracer accumulates in the tumor, it will be visible on MRI. With the cancer's molecular makeup identified through this virtual biopsy,
researches can load the"delivery system"with cancer-targeting components that specifically attack the molecular structure.
To show that the virtual biopsies could distinguish one cancer cell type from another, the researchers devised what is believed to be a unique method,
implanting different kinds of breast and lung cancers into laboratory mice to represent metastatic disease-with one type of cancer implanted on each side of the brain.
Lung and breast cancers are those that most often spread to the brain. The researchers used the nano delivery system to identify
and attack the cancers. In each instance, animals that received treatment lived significantly longer than those in control groups."
"Several drugs are quite effective in treating different types of breast cancers, lung cancer, lymphoma and other cancers at their original sites,
but they are ineffective against cancers that spread to the brain because they are not able to cross the blood-brain barrier that protects the brain from toxins in the blood,
"said Keith Black, MD, chair of the Department of Neurosurgery, director of the Maxine Dunitz Neurosurgical Institute, director of the Johnnie L. Cochran, Jr.,
Brain tumor Center and the Ruth and Lawrence Harvey Chair in Neuroscience.""The nanodrug is engineered to cross this barrier with its payload intact,
so drugs that are effective outside the brain may be effective inside as well,"Black added.#####Ljubimova, Black and Holler led the study
and contributed equally to the article. Rameshwar Patil, Phd, a project scientist in Ljubimova's laboratory, is first author.
Researchers from Cedars-Sinai's Department of Neurosurgery, Department of Biomedical sciences, Department of Imaging, and the Samuel Oschin Comprehensive Cancer Institute contributed to the study with colleagues from the University of Southern California and Arrogene Inc,
. a biotech company associated with Cedars-Sinai. The study was supported by NIH grants U01 CA151815, R01 CA136841, R01 CA188743,
The new NIH National Cancer Institute grant R01ca188743, will fund ongoing study.#####For more information, please click herecontacts:
"MRI Virtual Biopsy and Treatment of Brain Metastatic tumors with Targeted Nanobioconjugates.""Publication Date (Web: April 23, 2015.
May 27th, 2015fine-tuned molecular orientation is key to more efficient solar cells May 26th, 2015cancer Iranian Scientists Use Magnetic field to Transfer Anticancer Drug to Tumor Tissue May 24th,
The photonics advancement could improve early cancer detection, nanoelectronics manufacturing and scientists'ability to observe single molecules May 23rd,
The photonics advancement could improve early cancer detection, nanoelectronics manufacturing and scientists'ability to observe single molecules May 23rd, 2015aspen Aerogels to Present at the Cowen and Company Technology,
Synthetic pieces of biological molecule form framework and glue for making nanoparticle clusters and arrays May 25th, 2015nanostructures Increase Corrosion resistance in Metallic Body Implants May 24th, 2015iranian
Scientists Use Magnetic field to Transfer Anticancer Drug to Tumor Tissue May 24th, 2015discoveries Who needs water to assemble DNA?
The photonics advancement could improve early cancer detection, nanoelectronics manufacturing and scientists'ability to observe single molecules May 23rd,201 0
foam-like battery material that can withstand shock and stress.""It is possible to make incredible materials from trees
135 K) which caused the"high-Tc fever"in the world 30 years ago, it obviously exceeds the record of other"high-Tc superconductors"such as fullerene (C60) superconductors (Tc 33 K) and Mgb2 (Tc 39k),
"finding a nanothermometer sensitive enough at this scale is a great step forward in the field of nanotechnology, with applications in biology, chemistry, physics and even in the diagnosis and treatment of diseases
Molecular machines, novel sensors, bionic materials, quantum computers, advanced therapies and much more can emerge from this endeavour.
ICN2 researchers led by ICREA Prof Sergio O. Valenzuela have investigated hot carrier propagation across graphene using an electrical nonlocal injection/detection method.
diffuse away from the injection point and are detected electrically in a remote voltage probe by measuring the thermoelectric voltage.
Iranian researchers produced biocompatible and biodegradable nanocomposite scaffolds by using a type of natural silk with no cellular toxicity observed in the experiments.
It can also be used in the production of artificial skin or other medical stuff. In this research, nanocomposite scaffold was made of silk fibroin,
In addition, no sign of toxicity has been observed at the laboratorial scale. Results of the research have been published in RSC Advances,
2015new sensing tech could help detect diseases, fraudulent art, chemical weapons June 1st, 2015thin coating on condensers could make power plants more efficient:
News and information A step towards a type 1 diabetes vaccine by using nanotherapy June 10th, 2015investigation of Optical Properties of Quantum dots in Presence of Magnetic, Electrical Fields June 10th,
2015discoveries A step towards a type 1 diabetes vaccine by using nanotherapy June 10th, 2015investigation of Optical Properties of Quantum dots in Presence of Magnetic, Electrical Fields June 10th,
2015announcements A step towards a type 1 diabetes vaccine by using nanotherapy June 10th, 2015investigation of Optical Properties of Quantum dots in Presence of Magnetic, Electrical Fields June 10th,
2015interviews/Book reviews/Essays/Reports/Podcasts/Journals/White papers A step towards a type 1 diabetes vaccine by using nanotherapy June 10th,
but buckled due to changes of the internal stress in the layer during the etching process.
#New Sensors Measure Blood Anticoagulation Drug Iranian researchers from Isfahan University of Technology produced a highly sensitive and accurate sensor
which can measure a type of blood anticoagulation drug. The sensor was produced through a simple
Protamine is an important drug that is used as an anti-heparin agent to prevent blood coagulation during cardiovascular surgeries.
In addition to its high speed, this sensor minimizes environmental pollution due to the use of very low concentration of quantum dots in the production of the sensor and the lack of the need for toxic and organic solvents.
#Biomedical breakthrough: Carbon nanoparticles you can make at home Abstract: Researchers have found an easy way to produce carbon nanoparticles that are small enough to evade the body's immune system,
"The team tested the therapeutic potential of the nanoparticles by loading them with an anti-melanoma drug
In further experiments, the researchers found they could alter the infusion of the particles into melanoma cells by adjusting the polymer coatings.
"This is a versatile platform to carry a multitude of drugs-for melanoma, for other kinds of cancers and for other diseases,
so you can do multidrug therapy with the same particles.""""By using defined surface chemistry,
and are affiliated with Carle Foundation Hospital in Urbana, Illinois.##For more information, please click herecontacts:
The paper,"Tunable luminescent carbon nanospheres with well-defined nanoscale chemistry for synchronized imaging and therapy,"is available online:
2015cellulose from wood can be printed in 3-D June 17th, 2015new Sensors Measure Blood Anticoagulation Drug June 17th, 2015discoveries Scientists film shock waves in diamond:
Method could be useful in developing green energy and a better understanding of rust June 18th, 2015new Sensors Measure Blood Anticoagulation Drug June 17th,
Method could be useful in developing green energy and a better understanding of rust June 18th, 2015new Sensors Measure Blood Anticoagulation Drug June 17th,
#Nanowire implants offer remote-controlled drug delivery Abstract: Remote-controlled Eradication of Astrogliosis in Spinal cord Injury via Electromagnetically-induced Dexamethasone Release from"Smart"Nanowireswen Gao and Richard Borgenswe describe a system to deliver drugs to selected tissues continuously,
if required, for weeks. Drugs can be released remotely inside the small animals using pre-implanted,
and deposited onto a spinal cord lesion in Glial fibrillary acidic protein-luc Transgenic mices (GFAP-luc mice). Overexpression of GFAP is an indicator of astrogliosis/neuroinflammation in CNS injury.
The corticosteroid DEX, a powerful ameliorator of inflammation, was released from the polymer by external application of an Electromagnetic field for 2 hours/day for a week.
and non-invasively, opening the door to many other known therapies, such as the cases that dexamethasone cannot be applied safely systemically in large concentrations.
and wires required by other implantable devices that can lead to infection and other complications, said team leader Richard Borgens, Purdue University's Mari Hulman George Professor of Applied Neuroscience and director of Purdue's Center for Paralysis Research."
"This tool allows us to apply drugs as needed directly to the site of injury, which could have broad medical applications,
"Borgens said.""The technology is in the early stages of testing, but it is our hope that this could one day be used to deliver drugs directly to spinal cord injuries, ulcerations, deep bone injuries or tumors,
and avoid the terrible side effects of systemic treatment with steroids or chemotherapy.""The team tested the drug-delivery system in mice with compression injuries to their spinal cords
and administered the corticosteroid dexamethasone. The study measured a molecular marker of inflammation and scar formation in the central nervous system and found that it was reduced after one week of treatment.
A paper detailing the results will be published in an upcoming issue of the Journal of Controlled Release
Wen Gao, a postdoctoral researcher in the Center for Paralysis Research who worked on the project with Borgens
and transported a patch of the nanowire carpet on water droplets that were used used to deliver it to the site of injury.
The nanowire patches adhere to the site of injury through surface tension Gao said. The magnitude and wave form of the electromagnetic field must be tuned to obtain the optimum release of the drug,
Youngnam Cho, a former faculty member at Purdue's Center for Paralysis Research; and Jianming Li, a research assistant professor at the center.
GFAP is expressed in cells called astrocytes that gather in high numbers at central nervous system injuries. Astrocytes are a part of the inflammatory process and form a scar tissue,
A 1-2 millimeter patch of the nanowires doped with dexamethasone was placed onto spinal cord lesions that had been exposed surgically,
The lesions were closed then and an electromagnetic field was applied for two hours a day for one week.
###The research was funded through the general funds of the Center for Paralysis Research and an endowment from Mrs. Mari Hulman George. Borgens has a dual appointment in Purdue's College of Engineering and the College of Veterinary medicine.##
Cancer Nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis June 23rd, 2015news and information Nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis June 23rd, 2015sweeping lasers snap together nanoscale geometric grids:
New technique creates multilayered, self-assembled grids with fully customizable shapes and compositions June 23rd,
2015nanomedicine Nanoparticle'wrapper'delivers chemical that stops fatty buildup in rodent arteries Experimental therapy restores normal fat metabolism in animals with atherosclerosis June 23rd, 2015picosun ALD
breaks through in medical technology June 23rd, 2015nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis June 23rd,
2015newly-Developed Biosensor in Iran Detects Cocaine addiction June 23rd, 2015discoveries Nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis June 23rd, 2015sweeping lasers snap together nanoscale geometric grids:
New technique creates multilayered, self-assembled grids with fully customizable shapes and compositions June 23rd,
2015iranian Scientists Design Nano Device to Detect Cyanogen Toxic Gas June 23rd, 2015announcements Nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis June 23rd, 2015sweeping lasers snap together nanoscale geometric grids:
New technique creates multilayered, self-assembled grids with fully customizable shapes and compositions June 23rd,
2015interviews/Book reviews/Essays/Reports/Podcasts/Journals/White papers Nanoparticle'wrapper'delivers chemical that stops fatty buildup in rodent arteries Experimental therapy restores normal fat metabolism
2015nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis June 23rd, 2015iranian Scientists Design Nano Device to Detect Cyanogen Toxic Gas June 23rd,201 0
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011